Genentech (Roche Singapore) operates a biologics plant, formerly Lonza Biologics, which produces monoclonal antibodies and other biologics. This facility focuses on areas such as oncology, inflammation, and virology.
Subscribe to see Genentech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Genentech is a biotech company headquartered in United States. Xcout tracks 4 named people at Genentech, including Bob Swanson (Co-founder). Xcout recorded 246 job postings from Genentech in the last 90 days, naming tools such as SAP, PyTorch, GitHub.
Xcout recorded 246 job postings from Genentech in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Genentech's hiring signals →
A few of Genentech's closest competitors — see the full list of competitors and alternatives →
Abologix Sàrl is a biopharma and manufacturing company founded in 2018 and headquartered in Plan-les-Ouates, Geneva, Switzerland. It operates within the life sciences and antibodies sector.
Polpharma Biologics is a biotechnology company that develops and manufactures biosimilar medicines to improve patient access to biopharmaceuticals. Operating from Switzerland, the company manages a broad portfolio of biosimilars targeting major therapeutic areas and collaborates with global biopharmaceutical partners to bring these treatments from concept to commercial supply.
Singzyme is a Singapore-based biotechnology company pioneering next-generation bioconjugation solutions for manufacturing. Its mission is to deliver effective immunotherapies by developing safer and more homogenous, precision medicines.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Genentech? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.